Rankings
▼
Calendar
DFTX Q2 2017 Earnings — Definium Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
DFTX
Definium Therapeutics, Inc.
$2B
Q2 2017 Earnings
Healthcare
Medical - Pharmaceuticals
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$413,615
Net Income
-$410,931
EPS (Diluted)
$-1.75
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$73,335
Free Cash Flow
-$97,390
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$4M
Total Liabilities
$166,740
Stockholders' Equity
$4M
Cash & Equivalents
$79,876
← FY 2017
All Quarters
Q3 2017 →
